Tumour size and overall survival in a cohort of patients with unifocal glioblastoma: a uni- and multivariable prognostic modelling and resampling study
Name:
cancers-16-01301.pdf
Size:
1.936Mb
Format:
PDF
Description:
Found with Open Access Button
Affiliation
Division of Cancer Sciences, The University of Manchester, Manchester M13 9PL, UK. Department of Radiology, The Christie Hospital, Manchester M20 4BX, UK.Issue Date
2024
Metadata
Show full item recordAbstract
Published models inconsistently associate glioblastoma size with overall survival (OS). This study aimed to investigate the prognostic effect of tumour size in a large cohort of patients diagnosed with GBM and interrogate how sample size and non-linear transformations may impact on the likelihood of finding a prognostic effect. In total, 279 patients with a IDH-wildtype unifocal WHO grade 4 GBM between 2014 and 2020 from a retrospective cohort were included. Uni-/multivariable association between core volume, whole volume (CV and WV), and diameter with OS was assessed with (1) Cox proportional hazard models +/- log transformation and (2) resampling with 1,000,000 repetitions and varying sample size to identify the percentage of models, which showed a significant effect of tumour size. Models adjusted for operation type and a diameter model adjusted for all clinical variables remained significant (p = 0.03). Multivariable resampling increased the significant effects (p < 0.05) of all size variables as sample size increased. Log transformation also had a large effect on the chances of a prognostic effect of WV. For models adjusted for operation type, 19.5% of WV vs. 26.3% log-WV (n = 50) and 69.9% WV and 89.9% log-WV (n = 279) were significant. In this large well-curated cohort, multivariable modelling and resampling suggest tumour volume is prognostic at larger sample sizes and with log transformation for WV.Citation
Fatania K, Frood R, Mistry H, Short SC, O'Connor J, Scarsbrook AF, et al. Tumour Size and Overall Survival in a Cohort of Patients with Unifocal Glioblastoma: A Uni- and Multivariable Prognostic Modelling and Resampling Study. Cancers (Basel). 2024 Mar 27;16(7). PubMed PMID: 38610979. Pubmed Central PMCID: PMC11011077. Epub 2024/04/13. eng.Journal
Cancers (Basel)DOI
10.3390/cancers16071301PubMed ID
38610979Additional Links
https://dx.doi.org/10.3390/cancers16071301Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.3390/cancers16071301
Scopus Count
Collections
Related articles
- Tumour surface regularity predicts survival and benefit from gross total resection in IDH-wildtype glioblastoma patients.
- Authors: Lin P, Pang JS, Lin YD, Qin Q, Lv JY, Zhou GQ, Tan TM, Mo WJ, Chen G
- Issue date: 2025 Feb 17
- Impact of intensity standardisation and ComBat batch size on clinical-radiomic prognostic models performance in a multi-centre study of patients with glioblastoma.
- Authors: Fatania K, Frood R, Mistry H, Short SC, O'Connor J, Scarsbrook AF, Currie S
- Issue date: 2025 Jun
- EGFR amplification is a real independent prognostic impact factor between young adults and adults over 45yo with wild-type glioblastoma?
- Authors: Armocida D, Pesce A, Frati A, Santoro A, Salvati M
- Issue date: 2020 Jan
- Prognostic importance of temozolomide-induced neutropenia in glioblastoma, IDH-wildtype patients.
- Authors: Saito T, Sugiyama K, Hama S, Yamasaki F, Takayasu T, Nosaka R, Muragaki Y, Kawamata T, Kurisu K
- Issue date: 2018 Apr
- Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[(18)F]-fluoroethyl)-L-tyrosine PET.
- Authors: Bauer EK, Stoffels G, Blau T, Reifenberger G, Felsberg J, Werner JM, Lohmann P, Rosen J, Ceccon G, Tscherpel C, Rapp M, Sabel M, Filss CP, Shah NJ, Neumaier B, Fink GR, Langen KJ, Galldiks N
- Issue date: 2020 Jun